Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia. - Xu ZJ; Jin Y; Zhang XL; Xia PH; Wen XM; Ma JC; Lin J; Qian J (Cancer medicine, 2023)